Bell Investment Advisors, Inc Historic Quarter Change: Foreign ADRs, Reduced

Bell Investment Advisors, Inc historic quarter change: Foreign ADRs, Reduced

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Bell Investment Advisors, Inc opened 5 positions, added to 17, reduced 11 and sold out of 14.

Q1 2026: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 52.
Q4 2025: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 53.
Q3 2025: Stock ASTRAZENECA PLC; Country of operation —; Class SPONSORED ADR; Shares before 210.
Q3 2025: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 54.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1890149), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-07); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-17); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-24); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-21); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-11); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-16); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-07); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-08); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-08). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2021-09-30.

Quarter	Stock	Class	Shares before	Shares after	Share change	Value before	Value after	Value change	Filed
Q1 2026	ASCENDIS PHARMA A/S CUSIP 04351P101	SPONSORED ADR	52	25	-27	$11,089	$5,719	-$5,370	2026-04-17
Q4 2025	ASCENDIS PHARMA A/S CUSIP 04351P101	SPONSORED ADR	53	52	-1	$10,537	$11,089	+$552	2026-02-24
Q3 2025	ASTRAZENECA PLC CUSIP 046353108	SPONSORED ADR	210	174	-36	$14,675	$13,350	-$1,325	2025-11-21
Q3 2025	ASCENDIS PHARMA A/S CUSIP 04351P101	SPONSORED ADR	54	53	-1	$9,321	$10,537	+$1,216	2025-11-21
Q1 2025	JAMES HARDIE INDS PLC CUSIP 47030M106	SPONSORED ADR	130	107	-23	$4,006	$2,521	-$1,485	2025-05-16
Q4 2024	ASTRAZENECA PLC CUSIP 046353108	SPONSORED ADR	186	132	-54	$14,492	$8,649	-$5,843	2025-02-07
Q4 2024	JAMES HARDIE INDS PLC CUSIP 47030M106	SPONSORED ADR	162	130	-32	$6,505	$4,006	-$2,499	2025-02-07
Q4 2024	ASCENDIS PHARMA A/S CUSIP 04351P101	SPONSORED ADR	57	44	-13	$8,511	$6,058	-$2,453	2025-02-07
Q4 2024	CRITEO S A CUSIP 226718104	SPONS ADS	139	96	-43	$5,594	$3,798	-$1,796	2025-02-07
Q2 2024	JAMES HARDIE INDS PLC CUSIP 47030M106	SPONSORED ADR	171	147	-24	$6,919	$4,637	-$2,282	2024-08-08
Q1 2024	TOTALENERGIES SE CUSIP 89151E109	SPONSORED ADS	112	53	-59	$7,547	$3,648	-$3,899	2024-05-08

Similar Firms

Firm Name	Country	13F Value	Holdings
ADVOCATE GROUP LLC	United States	$0.639B	126
Stamos Capital Partners, L.P.	United States	$0.640B	142
SevenBridge Financial Group, LLC	United States	$0.640B	202
PenderFund Capital Management Ltd.	Canada	$0.639B	253
Global Wealth Management Investment Advisory, Inc.	United States	$0.638B	158
St. James Investment Company, LLC	United States	$0.638B	22
BEARING POINT CAPITAL, LLC	United States	$0.638B	166
WILSEY ASSET MANAGEMENT INC	United States	$0.638B	25
Kultura Capital Management LP	United States	$0.638B	53
ROBOTTI ROBERT	United States	$0.641B	78